Back to 
BlackRock, Inc.
BlackRock, Inc.
CTMX7 quarters
Position history for BlackRock, Inc.'s holdings in CYTOMX THERAPEUTICS INC.
BlackRock, Inc. holds 17.6M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $65.8M as of 2026-Q2. The position was increased (+235.9% shares). CTMX represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$65.8M
Current Shares
17.6M
Total Value Change
+$64.6M
Total Shares Change
+16.3M
Quarter-by-Quarter History
Other major holders of CTMX: FMR LLC, BNP PARIBAS FINANCIAL MARKETS, BANK OF AMERICA CORP /DE/